CoChat

Neuroprotective effect of linagliptin against cuprizone-induced demyelination and behavioural dysfunction in mice: A pivotal role of AMPK/SIRT1 and JAK2/STAT3/NF-κB signalling pathway modulation

Elbaz, Eman M., Senousy, Mahmoud A., El-Tanbouly, Dalia M., Sayed, Rabab H. · 2018 · Toxicology and Applied Pharmacology
Cited by 112

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

&NA; Multiple sclerosis is a chronic inflammatory demyelinating central nervous system disorder leading to serious neurological deficits. Linagliptin, a dipeptidyl peptidase‐4 inhibitor, recently showed neuroprotective properties against neurodegenerative diseases. This study investigated the possible neuroprotective effect of linagliptin against cuprizone‐induced demyelination in mice and its potential early‐remyelinating properties. C57Bl/6 mice were fed chow containing 0.7% cuprizone for 1 week, followed by 3 weeks of a 0.2% cuprizone diet. Linagliptin (10 mg/kg/day, p.o.) was given for 3 weeks starting from the second week. Linagliptin treatment improved behavioural and motor abnormalities induced by cuprizone, as demonstrated by open field, rotarod and grip strength tests. In parallel, linagliptin lessened the demyelination through enhancing Olig2 gene expression, as shown by increased myelin basic protein, myelin proteolipid protein levels and Luxol fast blue‐staining intensity. Linagliptin attenuated cuprizone‐induced oxidative stress by decreasing brain thiobarbituric acid reactive substances along with restoring reduced glutathione levels. Linagliptin exerted an anti‐inflammatory effect by reducing brain tumor necrosis factor‐alpha. Interestingly, linagliptin diminished phosphorylated JAK2, phosphorylated STAT3 and NF‐&kgr;B p65 protein expression while up‐regulating phosphorylated AMP‐activated protein kinase (p‐AMPK) protein and SIRT1 gene expression levels. In conclusion, linagliptin exerted a neuroprotective effect in mice with cuprizone‐induced demyelination possibly by modulating AMPK/SIRT1 and JAK2/STAT3/NF‐&kgr;B signalling pathways. HighlightsLinagliptin improved the behavioural abnormalities induced by the cuprizone diet.Linagliptin lessened the cuprizone‐induced demyelination and showed early remyelinating effects.Linagliptin attenuated cuprizone‐induced oxidative stress.Linagliptin exerted an anti‐inflammatory effect.Linagliptin modulated the AMPK/SIRT1 and JAK2/STAT3/NF‐&kgr;B signalling pathway.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.taap.2018.05.035

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 112

Metadata

Authors
Elbaz, E. M., Senousy, M. A., El-Tanbouly, D. M., & Sayed, R. H.
Venue
Toxicology and Applied Pharmacology
Publisher
Elsevier BV
Published
2018-08
Volume
352
Pages
153-161
ISSN
0041-008X (ISSN-L)
OpenAlex
W2807536020
Cited by
112
References
16
FWCI
6.43
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.